Tramadol: does it have a role in emergency medicine?
- PMID: 15675908
- DOI: 10.1111/j.1742-6723.2005.00671.x
Tramadol: does it have a role in emergency medicine?
Abstract
Tramadol is a synthetic analgesic new to the Australasian market where its use is rapidly increasing. It is used extensively overseas, particularly in Europe where it has been popular since its introduction in Germany in the late 1970s. Tramadol has a dual mechanism of action: weak mu opioid receptor agonist and a reuptake inhibitor of serotonin and noradrenaline. Thus, it has distinct advantages and disadvantages compared to other available analgesics. Its use is advocated in a variety of acute and chronic pain states as well as some non-analgesic applications. The use of tramadol in an emergency setting is not well studied, with most published trials assessing its efficacy and tolerability in postoperative or dental models. This literature review concludes that tramadol does not offer any particular benefits over existing analgesics for the majority of emergency pain relief situations.
Similar articles
-
Combination analgesia in 2005 - a rational approach: focus on paracetamol-tramadol.Clin Rheumatol. 2006;25 Suppl 1:S16-21. doi: 10.1007/s10067-006-0202-9. Epub 2006 Jun 2. Clin Rheumatol. 2006. PMID: 16741784 Review.
-
Tramadol. Focus on musculoskeletal and neuropathic pain.Minerva Anestesiol. 2005 Oct;71(10):565-84. Minerva Anestesiol. 2005. PMID: 16163147 Review. English, Italian.
-
Paracetamol + tramadol: new preparation. No advance.Prescrire Int. 2003 Dec;12(68):211-3. Prescrire Int. 2003. PMID: 14986689
-
The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol.Neuropharmacology. 2008 Feb;54(2):331-43. doi: 10.1016/j.neuropharm.2007.10.005. Epub 2007 Oct 16. Neuropharmacology. 2008. PMID: 18037451
-
Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain.Curr Med Res Opin. 2007 Oct;23(10):2531-42. doi: 10.1185/030079907X233179. Curr Med Res Opin. 2007. PMID: 17825129 Clinical Trial.
Cited by
-
Analgesia use in trauma patients at a university teaching hospital in Kigali, Rwanda.Afr J Emerg Med. 2023 Sep;13(3):147-151. doi: 10.1016/j.afjem.2023.05.002. Epub 2023 Jun 7. Afr J Emerg Med. 2023. PMID: 37334174 Free PMC article.
-
Comparative pharmacokinetics between two tablets of tramadol 37.5 mg/acetaminophen 325 mg and one tablet of tramadol 75 mg/acetaminophen 650 mg for extended-release fixed-dose combination.Transl Clin Pharmacol. 2022 Jun;30(2):112-119. doi: 10.12793/tcp.2022.30.e12. Epub 2022 Jun 27. Transl Clin Pharmacol. 2022. PMID: 35800670 Free PMC article.
-
Chronic non-cancer pain: Focus on once-daily tramadol formulations.Ther Clin Risk Manag. 2007 Oct;3(5):819-29. Ther Clin Risk Manag. 2007. PMID: 18473006 Free PMC article.
-
Tramadol Dependence: A Case Report.Med J Armed Forces India. 2010 Jan;66(1):93-4. doi: 10.1016/S0377-1237(10)80114-5. Epub 2011 Jul 21. Med J Armed Forces India. 2010. PMID: 27365718 Free PMC article. No abstract available.
-
Revisiting Tramadol: A Multi-Modal Agent for Pain Management.CNS Drugs. 2019 May;33(5):481-501. doi: 10.1007/s40263-019-00623-5. CNS Drugs. 2019. PMID: 31004280 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials